InternationalUSRemember you can easily switch between MIP US and MIP International at any time

UPC scenario 2: a blockbuster drug patent with an SPC

Managing Intellectual Property


In our second discussion of a hypothetical UPC scenario, Duncan Ribbons and Rebecca Lawrence address some of the complications that arise with SPCs, licences, opt outs and injunctions

The Unified Patent Court (UPC) promises to herald a new dawn for patent litigation in Europe. Pan-European injunctions and central revocation will become normal, whereas under the current system injunctions and revocations must be obtained on a country-by-country basis. However,...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Mexico amends its trade mark opposition system https://t.co/FOWV5GmVo6 Legislation that amends Mexico’s trade mark… https://t.co/X6imNoP8dL

Apr 20 2018 02:41 ·  reply ·  retweet ·  favourite
ManagingIP profile

Lijun Kong and Quan Kang of DEQI analyse a number of cases in which the courts have considered supplementary experi… https://t.co/av6fDpHQNy

Apr 20 2018 01:00 ·  reply ·  retweet ·  favourite
ManagingIP profile

Tina Tai and Guo Yu of China Patent Agent examine the difficulty of having supplementary experimental data consider… https://t.co/Ovz2zcbPOl

Apr 20 2018 08:00 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

April 2018

Special Report: Will blockchain revolutionise IP?

In this special report, Managing IP looks at how blockchain technology will change intellectual property. Ellie Mertens analyses the issues and opportunities it presents for patents, trade mark and copyright



Most read articles

Supplements